Moderna’s CEO came out with a bold statement predicting existing vaccines will struggle against the omicron mutation. These remarks come at a time when virtually no evidence exists that current shots will not protect against omicron. The company is currently developing a vaccine designed specifically to target the mutation. But is Moderna moving too quickly or is this a sound measure of precaution given the unknown potential impact of omicron?